BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao F, Sun J, Wang G, Xie H, Zhu X, Zhang J. Liquid chromatographic–mass spectrometry analysis and pharmacokinetic studies of a novel rabeprazole formulation, sterile powder for injection, in dogs and rats. Biopharm Drug Dispos 2007;28:177-86. [DOI: 10.1002/bdd.543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Dash RP, Rais R, Srinivas NR. Stereoselective and nonstereoselective pharmacokinetics of rabeprazole – an overview. Xenobiotica 2018;48:422-32. [DOI: 10.1080/00498254.2017.1307470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Kosugi Y, Yamamoto S, Sano N, Furuta A, Igari T, Fujioka Y, Amano N. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion. J Pharm Sci 2015;104:2887-93. [PMID: 25720462 DOI: 10.1002/jps.24401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
3 Nawaz MS. Validation and application of a new reversed phase HPLC method for in vitro dissolution studies of rabeprazole sodium in delayed-release tablets. J Anal Methods Chem 2013;2013:976034. [PMID: 24062966 DOI: 10.1155/2013/976034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Gao Y, Xu J, Su Z, Song L, Lou H. The chiral bioconversion and preclinical pharmacokinetic analysis of ( R )-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS: The chiral bioconversion and pharmacokinetic of ( R )-(+)-rabeprazole. Biomed Chromatogr 2013;27:1380-6. [DOI: 10.1002/bmc.2932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
5 Buchireddy R, Mukkanti K, Srinivasulu P, Srinivas KSV. A Validated, Stability-Indicating, LC Method for Rabeprazole Sodium. Chroma 2008;68:275-80. [DOI: 10.1365/s10337-008-0670-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]